Exogenous transforming growth factor β2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats

Journal of Surgical Research

Volumn 87, Issue 2, 1999, Pages 194-200

  Wang, Xue ^a   Smith, Paul ^a   Pu, Lee L Q ^a   Kim, Y J ^a   Ko, Francis ^a   Robson, Martin C ^a  

^a NONE

Author keywords

Burn hypertrophic scar; Keloid scar; Nude rat; Transforming growth factor ; Transforming growth factor antibody

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; KELOID; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SCAR FORMATION; WOUND HEALING; XENOGRAFT;

EID: 0033406340     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5757     Document Type: Article

References (32)

1. Murray J. C. Scars and keloids. Dermatol. Clin. 11:1993;697.
2. Thomas D. W., Hopkinson I., Harding K. G., Shepherd J. P. The pathogenesis of hypertrophic/keloid scarring. Int. J. Oral Maxillofac. Surg. 23:1994;232.
3. Shetlar M. R., Shetlar C. L., Hendricks L., Kischer C. W. The use of athymic nude mice for the study of human keloids. Proc. Soc. Exp. Biol. Med. 179:1985;549.
4. Kischer C. W., Pindur J., Shetlar M. R., Shetlar C. L. Implants of hypertrophic scars and keloids into the nude (athymic) mouse: Viability and morphology. J. Trauma. 29:1989;672.
5. Estrem S. A., Domayer M., Bardach J., Cram A. E. Implantation of human keloid into athymic mice. Laryngoscope. 97:1987;1214.
6. Hayward P. G., Linares H. A., Evans M. J., McCauley R. L., Robson M. C. A model of human keloid using the nude (athymic) rat. Surg. Forum. 42:1991;612.
7. Polo M., Kim Y. J., Kucukcelebi A., Hayward G. H., Ko F., Robson M. C. An in vivo model of human proliferative scar. J. Surg. Res. 74:1998;187.
8. Robson M. C. Growth factors as wound healing agents. Curr. Opin. Biochem. 2:1991;863.
9. 1 gene and protein changes during human partial thickness wound healing. Wounds. 10:1998;76.
10. Kingsnorth A. N., Slavin J. Peptide growth factors and wound healing. Br. J. Surg. 78:1991;1286.
11. Sporn M. B., Robert A. B. Transforming growth factor-β: Multiple action and potential clinical application. JAMA. 262:1989;938.
12. Roberts A. B., Sporn M. B. Transforming growth factor beta. Adv. Cancer Res. 51:1988;107.
13. Massague J. The transforming growth factor-beta family: A Review. J. Cell Biol. 6:1990;597.
14. Joyce M. E., Roberts A. B., Sporn M. B., Bolander M. E. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 10:1990;2195.
15. Ksander G. A., Ogawa Y. A. M., Chu G. H., McMullin H., Rosenblatt J. S., Mcpherson J. M. Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann. Surg. 211:1990;288.
16. 1,2 reduce cutaneous scarring in adult rodents. J. Cell Sci. 107:1994;1137.
17. Shah M., Foreman D. M., Ferguson M. W. J. Neutralizing antibody to TGF-beta1 and TGF-beta2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108:1995;985.
18. Polo M., Ko F., Busillo F., Cruse C. W., Krizek T. J., Robson M. C. The 1997 Moyer Award: Cytokine production in patients with hypertrophic burn scars. J. Burn Care Rehab. 18:1997;477.
19. 2 increases DNA synthesis and collagen production in keloid fibroblasts. Surg. Forum. 16:1998;677.
20. Datubo-Brown D. D. Keloids: A review of the literature. Br. J. Plast. Surg. 43:1990;70.
21. Muir I. F. K. On the nature of keloid and hypertrophic scars. Br. J. Plast. Surg. 43:1990;61.
22. Lawrence W. T. In search of the optimal treatment of keloids: Report of a series and a review of the literature. Ann. Plast. Surg. 27:1991;164.
23. Kischer C. W. Comparative ultrastructure of hypertrophic scars and keloids. Scanning Electron Microsc. 1:1984;423.
24. 2 on proliferative scar fibroblast cell kinetics, Ann. Plast. Surg, in press.
25. Ghahary A., Shen Y. J., Scott P. G., Gong Y., Tredget E. E. Enhanced expression of mRNA for transforming growth factor-b, type I and type III procollagen in human post-burn hypertrophic scar tissues. J. Lab. Clin. Med. 122:1993;465.
26. Zhang K., Warren G., Cohen, Rodrigues J., Phan S. Increased types I and III collagen and transforming growth factor-b1 mRNA and protein in hypertrophic burn scar. J. Invest. Dermatol. 104:1995;750.
27. Schmid P., Itin P., Cherry G., Bi C., Cox D. A. Enhanced expressions of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am. J. Pathol. 152:1998;485.
28. Quaglino D., Nanney L. B., Kennedy R., Davidson J. M. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix expression in pig skin. Lab. Invest. 63:1990;307.
29. Younai S., Nichter L. S., Wellisz T., Reinisch J., Nimni M. E., Tuan T. L. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann. Plast. Surg. 33:1994;148.
30. Cox D. A. Transforming growth factor-beta 3. Cell Biol. Int. 19:1995;357.
31. Wu L. C., Siddiqui A., Morris D. E., Cox D. A., Roth S. L., Mustoe T. A. Transforming growth factor-beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence: Histologic and competitive reverse-transcription polymerase chain reaction. Arch. Surg. 132:1997;753.
32. 2 activates proliferative scar fibroblasts. J. Surg. Res. 82:1999;319.